Diagnostic Tools for Alzheimer’s Disease

For more than 25 years, Fujirebio has led the development of biomarker-based solutions for Alzheimer’s disease, beginning with cerebrospinal fluid (CSF) testing and now advancing into blood-based diagnostics. 

CSF biomarkers—such as beta amyloid (Aβ1-42 and Aβ1-40) and Tau proteins (Total Tau and phospho-Tau) have transitioned from research tools to routine clinical use, enabling early and accurate detection of Alzheimer’s pathology. 

Today, Fujirebio is pioneering blood-based biomarkers (BBM) that offer a less invasive, more accessible option for assessing disease risk. Fully automated assays for key proteins, including Aβ1-42, Aβ1-40, and pTau 181, are available for research use, alongside emerging markers like NPTX2 and sTREM2. Through ongoing innovation and global collaboration, Fujirebio is shaping the future of Alzheimer’s diagnostics—bringing testing closer to the patient and supporting earlier clinical decision-making.

Learn more below our high-quality biomarkers for Alzheimer's disease and other neurodegenerative diseases below or contact us today

Lumipulse® Assays 

Insights

Insight articles

Interested in Learning More? Download our Brochures.

For more information on the FDA-cleared Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio & Lumipulse® G β-Amyloid (1-42/1-40) Ratio tests and our robust menu of other high-quality biomarkers of neurodegeneration*, request to view and download our brochures and additional information below:

  • Plasma Ratio Brochure
  • Plasma Ratio Interpretation and Collection Guide
  • CSF Amyloid Ratio Brochure
  • CSF Amyloid Ratio Interpretation and Collection Guide
  • GFAP—NfL Sales Sheet
  • Neuro Capabilities Brochure
  • LUMIPULSE® G1200 Analyzer Brochure

Download Brochures

*All tests are designed for use on the LUMIPULSE® G1200 Analyzer.

Interested in Learning More? Download our Brochures.

For more information on the FDA-cleared Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio & Lumipulse® G β-Amyloid (1-42/1-40) Ratio tests and our robust menu of other high-quality biomarkers of neurodegeneration*, request to view and download our brochures and additional information below:

  • Plasma Ratio Brochure
  • Plasma Ratio Interpretation and Collection Guide
  • CSF Amyloid Ratio Brochure
  • CSF Amyloid Ratio Interpretation and Collection Guide
  • GFAP—NfL Sales Sheet
  • Neuro Capabilities Brochure
  • LUMIPULSE® G1200 Analyzer Brochure

Download Brochures

*All tests are designed for use on the LUMIPULSE® G1200 Analyzer.

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.